Disparities in the Use of SGLT2 Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Adults With CKD in the United States

Affiliations

• ¹ Department of Medicine, Division of Nephrology, David Geffen School of Medicine, University of California, Los Angeles, California.
• ² Providence Medical Research Center, Providence Inland Northwest, Spokane, Washington.
• ³ Department of Medicine, University of Washington, Seattle, Washington.
• ⁴ Lundquist Institute at Harbor-UCLA Medical Center, Torrance, California.